COFEPRIS vs. FDA: What’s the Difference and Why Does It Matter?
Learn what COFEPRIS is, how it compares to the FDA, and why choosing a COFEPRIS-authorized provider matters when traveling to Mexico for medical care.
If you're considering traveling to Mexico for medical treatment, you've probably heard the term COFEPRIS.
But what exactly does it mean? And why should it matter when choosing a medical provider?
Understanding COFEPRIS is an important part of making an informed decision about medical care in Mexico. Regardless of the procedure you are planning to get, knowing how medical facilities and treatments are regulated can help you make a more informed choice.
At TreVita, we believe information is power. We empower our clients with the knowledge and science they need to make thoughtful, informed decisions about their care. If you're considering medical treatment abroad, understanding the regulatory environment is an important part of that process. That starts with knowing what COFEPRIS is, what it regulates, and what its authorization means for you as a patient.
What Is COFEPRIS?
COFEPRIS stands for Comisión Federal para la Protección contra Riesgos Sanitarios, or the Federal Commission for the Protection against Sanitary Risks.
It is one of Mexico's primary health and sanitary regulatory authorities. Its role includes regulating and monitoring products, establishments, services, and activities that may affect public health.
Its responsibilities cover a wide range of areas:
Depending on the type of facility, product, or activity involved, COFEPRIS can issue different types of licenses, permits, registrations, and other regulatory authorizations. For patients traveling to Mexico, this means COFEPRIS plays an important role in the country's overall health and safety regulatory framework.
What Does COFEPRIS Actually Regulate?
One of the most important things to understand is that COFEPRIS does more than simply "approve" products or providers. Its responsibilities can involve facilities, products, and clinical research; these are separate areas of oversight.
Health Care Facilities
Certain health care facilities in Mexico must have the appropriate sanitary authorization before operating. Depending on the type of facility and its activities, this may include a sanitary license or a notice of operation and a responsible sanitary professional. These are not necessarily the same thing. A notice of operation, for example, is a regulatory requirement for certain establishments but is not itself considered a sanitary authorization.
This distinction matters when evaluating a medical facility.
Health-Related Products
Depending on the product, this can involve sanitary registration, manufacturing licenses, import permits, distribution permissions, product release authorizations, and GMP certifications. A facility may have authorization to operate, but that does not automatically mean that every product associated with that facility has been individually approved or registered.
Clinical Research
COFEPRIS also has a role in the authorization and oversight of clinical research involving human subjects, a separate matter from operating authorization.
A facility may have authorization to operate, but that does not automatically mean every product associated with that facility has been individually approved or registered. And a clinic being authorized to operate does not automatically mean every treatment it offers has been proven safe and effective through clinical trials. Facility authorization, product authorization, and clinical evidence are separate considerations.
How Is COFEPRIS Similar to the FDA?
For patients in the United States, one simple way to understand COFEPRIS is to compare it to the U.S. Food and Drug Administration (FDA). Both agencies play important roles in protecting public health and regulating areas such as:
However, COFEPRIS and the FDA are not identical agencies. They operate within different health care systems and have different responsibilities and regulatory processes.
A simple way to think about it is:
Both are national regulatory authorities that help protect public health, but their specific powers and regulatory systems differ. COFEPRIS also works with international regulatory authorities, including the FDA, through regulatory cooperation and information-sharing agreements.
Does COFEPRIS Regulate Other Countries?
No. COFEPRIS is Mexico's national regulatory authority. It does not serve as the health regulator for other countries. Countries and regions have their own regulatory authorities:
Regulatory agencies do not operate completely independently. They often cooperate, share information, and work toward greater regulatory alignment. COFEPRIS participates in international regulatory initiatives and has established mechanisms for cooperation with organizations and authorities in other countries.
The important takeaway: COFEPRIS applies to Mexico. A medical provider in another country is subject to the regulatory requirements of that country's relevant authorities.
Why Should You Choose a COFEPRIS-Authorized Provider?
When traveling to Mexico for medical care, choosing a provider that operates within the country's applicable health regulatory framework is an important part of protecting yourself as a patient.
Depending on the type of facility and services provided, a medical establishment may need a sanitary license, notice of operation, or another type of authorization. Choosing a provider with the appropriate COFEPRIS authorization can give patients greater confidence that the facility operates within Mexico's established health and sanitary regulations.
COFEPRIS oversight can extend beyond the surgeon to the facility, surgical procedures, medical devices, implants, injectables, and anesthetics used in patient care. Each component plays an important role in maintaining appropriate health and safety standards.
For bariatric procedures, COFEPRIS oversight includes the hospital or surgical facility, medical devices used during surgery, and applicable facility authorizations. These requirements help ensure that the surgical environment meets established health and safety standards.
COFEPRIS oversight can apply to the clinic or facility, as well as the products and medical materials used during treatment. Any biologic products or additional therapies may also be subject to their own regulatory requirements.
Stem cell therapy involves an additional layer of consideration because the biological product itself must also be evaluated. Beyond the facility and medical team, factors such as cell quality, viability, and product handling are important when assessing the overall quality and safety of treatments.
Choosing a COFEPRIS-authorized provider is an important step, but at TreVita, we go beyond regulatory requirements.
We take a comprehensive approach to vetting the providers we work with, evaluating the many factors that contribute to safe, high-quality patient care. To help ensure the highest standards of quality and the best possible outcomes, we partner with doctors, clinics, and facilities that are not only COFEPRIS-authorized but also hold additional national and international certifications that demonstrate their commitment to quality and patient care.
TreVita’s Partnered Doctor Certifications Include:
Does COFEPRIS Guarantee the Quality of Every Treatment?
Not necessarily.
This is an important distinction for anyone considering medical treatment abroad.
COFEPRIS oversight or authorization can be an important part of a regulatory framework. However, it should not automatically be viewed as a guarantee that every treatment from a facility will produce a specific outcome or that every aspect of a patient's experience will meet their expectations.
The type of treatment you're receiving also matters.
The takeaway is that regulatory oversight is an important starting point, but patients should also look at the specific details of the treatment they're receiving.
Take Stem Cell Therapy, for Example
Stem cell therapy provides a useful example of why patients should look beyond a provider's general regulatory status. A provider's authorization does not necessarily tell a patient everything about the specific cellular product they will receive.
Patients may also want to ask:
TreVita's independent study examined stem cell products from multiple providers in Mexico and found significant differences between advertised and independently measured cell counts and viability.
Delivered fewer than 25% of the expected viable cell dose.
Measured viability ranged from 18% to 94% across samples.
These findings highlight why patients may benefit from additional, product-specific verification beyond a provider's general regulatory status.
See How TreVita Verifies Stem Cell Quality
TreVita believes patients deserve transparency about the treatments they receive.
That's why we conducted an independent study examining stem cell quality and provide clients with a Certificate of Analysis that offers additional information about their specific stem cell product.
The Bottom Line: Do Your Research Before Medical Travel
Choosing a COFEPRIS-authorized provider is an important first step when traveling to Mexico for medical care. But it's not the only step.
Whether you're considering plastic surgery, bariatric surgery, hair restoration, or stem cell therapy, take the time to understand your provider, your facility, your treatment, and the standards in place to support your care.
Ask questions. Review credentials. Understand the regulatory framework. And make sure you have clear information about what to expect before, during, and after your treatment.
At TreVita, we believe informed patients make confident decisions.
Because your health deserves more than a quick search. It deserves careful research, transparency, and the right support from start to finish.
Choose a COFEPRIS-authorized provider.
Whatever you are traveling for — bariatric surgery, plastic surgery, hair restoration, or stem cell therapy — confirm the facility holds the appropriate COFEPRIS authorization for the care it provides.